Products
19093 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 98.88 | 1.92 | 0.040 | 1.96 | 1 | -9.43% | -46.37% | -35.57% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 98.88 | 0.68 | 0.030 | 0.71 | 1 | 1.49% | 33.33% | 6.25% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 98.88 | 2.19 | 0.030 | 2.22 | 1 | 2.82% | 25.86% | 8.42% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 98.88 | 1.01 | 0.030 | 1.04 | 1 | 8.60% | 83.64% | 3.06% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 98.88 | 0.16 | 0.030 | 0.19 | 1 | -11.11% | 33.33% | -11.11% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 98.88 | 1.73 | 0.040 | 1.77 | 1 | 7.45% | 69.61% | 7.45% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 2.5 | 0.080 | 2.58 | 1 | -27.33% | -41.45% | -67.49% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 0.018 | ― | ― | 1 | -5.26% | -10.00% | -10.00% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 4.72 | 0.110 | 4.83 | 1 | -20.40% | -32.18% | -50.94% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -50.00% | 9 Jul. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 7.56 | 0.100 | 7.66 | 1 | -13.40% | -21.74% | -32.62% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 324.562 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 324.562 | 8.02 | 0.090 | 8.11 | 1 | 10.16% | 20.97% | 4.56% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 324.562 | 0.74 | 0.030 | 0.77 | 1 | 12.12% | 27.59% | -6.33% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 324.562 | 0.44 | 0.030 | 0.47 | 1 | 12.82% | 33.33% | -24.14% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 204.187 | 226.02 | 0.490 | 226.51 | 1 | -7.72% | 50.43% | 28.57% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 204.187 | 254.61 | 1.280 | 255.89 | 1 | -19.95% | 143.37% | 23.90% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 204.187 | 34.89 | 0.080 | 34.97 | 1 | -9.70% | 64.50% | 32.51% | 27 Jun. 2022 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.